Evaluation of romiplostim in a randomized placebo-controlled phase 3 study of a Japanese population with chronic immune thrombocytopenia (ITP)

Authors
Category Primary study
JournalBlood
Year 2010
This article has no abstract
Epistemonikos ID: 96dd6e901a07eb8de6ec1293e72719bb37b79de5
First added on: Feb 05, 2025